JPRN-jRCT2051220160招募中Unknown
An Expanded Access Program of CNT-01 in Patients with Idiopathic Triglyceride Deposit Cardiomyovasculopathy
Akita Yasuhiko0 个研究点目标入组 60 人开始时间: 2023年1月30日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who completed the 52 weeks of administration in the CNT-01-811 study.
- •Patients who voluntarily signed and dated the informed consent form.
排除标准
- •Patients with diabetic ketoacidosis.
- •Patients allergic to the ingredients of the investigational product.
研究者
相似试验
进行中（未招募）
2 期
Phase IIb/III Clinical Study of CNT-01 in Patients with Idiopathic Triglyceride Deposit CardiomyovasculopathyIdiopathic triglyceride deposit cardiomyovasculopathyJPRN-jRCT2051210177Akita Yasuhiko60
招募中
3 期
Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene CiloleucelJPRN-jRCT2033230370Gina Bonaccorso10
已完成
2 期
Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.on-small cell lung cancerJPRN-UMIN000000817agasaki Thoracic Oncology Group32
已完成
1 期
Phase I/IIa Study of CNT-01 in Patients with Idiopathic Triglyceride Deposit CardiomyovasculopathyIdiopathic Triglyceride Deposit CardiomyovasculopathyJPRN-UMIN000018289Ken-ichi Hirano, Department of Cardiovascular Medicine, Osaka University Grduate School of Medicine6
招募中
2 期
Phase IIa trial of CNT-01 for patients with idiopathic triglyceride deposit cardiomyovasculopathy.JPRN-UMIN000035403Osaka university hospital20